-+ 0.00%
-+ 0.00%
-+ 0.00%

VANDA PHARMACEUTICALS - IMSIDOLIMAB BLA FOR GPP UNDER FDA REVIEW WITH TARGET ACTION DATE DECEMBER 12, 2026

Reuters·07/16/2026 20:30:09

Please log in to view news